2026.07.30
XI News | Wishing Shanghai Xichang Bio a happy third anniversary!
Thank you for being with us—hand in hand, we’ve witnessed 1,095 days, from the moment the seed was first planted to the tender sprout that has now emerged. Over the course of three years, the seed sown long ago has quietly begun to bud.
2026.01.29
On January 25, 2026, at the launch ceremony of “OriStar,” a startup community for young biomedical scientists initiated by the Haihuo Tiancheng Club, Dr. Tao Weihong, Founder and CEO of Xichang Bio, and Dr. He Yusheng, Founder and CEO of Xunmeng Bio, formally signed a strategic cooperation agreement on behalf of their respective companies. This marks the beginning of a new chapter in which these two innovative enterprises, both deeply rooted in the biopharmaceutical sector, will join forces to pursue technological synergy and mutually beneficial growth.
2025.12.04
XI News | Xichang Bio Has Successfully Been Recognized as a National High-Tech Enterprise!
Good news keeps pouring in—another honor has been bestowed! After rigorous review and a period of public announcement, Xichang Bio has officially been certified as a National High-Tech Enterprise, earning this prestigious national-level accreditation that underscores the company’s innovative strength.
2025.12.03
Recently, the finals of the 2025 “Innovation·Shanghai” International Innovation and Entrepreneurship Competition concluded successfully! Shanghai Constream biotechnology Co., Ltd. stood out among numerous outstanding enterprises with its cutting-edge technological achievements, a clear commercialization roadmap, and strong growth potential, securing third place in the Startup Category and earning industry recognition and prestigious accolades through its exceptional performance.
2025.11.20
Precisely targeting tumor cells while sparing healthy tissues has long been a central goal for researchers. A recent study published in Antibodies ingeniously leverages the acidic microenvironment of tumors to develop a pH‑dependent anti‑AXL antibody, offering a novel approach to addressing the challenge of off‑target toxicity in targeted therapies.
2025.11.11
XI News | Xichang Bio Wins the Grand Prize in the Startup Category of “Innovation·Shanghai 2025”!
Recently, at the 2025 “Innovation · in Shanghai” International Innovation and Entrepreneurship Competition, the official list of winners was announced. Shanghai Constream biotechnology Co., Ltd. stood out from thousands of participating projects with its robust capabilities and innovative potential in the field of antibody drug development, earning the title of Outstanding Enterprise in the Startup Category!
2025.08.29
“Targeting” the Lead: The Next-Generation Star of Immunotherapy—AOAH!
Recently, Cell published a research paper titled “Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy.” Using the innovative Cancer Immunology Data Engine (CIDE) system, the study analyzed 8,575 tumor‑omics datasets from 5,957 patients and identified AOAH—among 1,903 human secreted proteins—as the most prominent candidate for enhancing immunotherapy.
2025.08.18
Xi News | Xichang Bio’s Asia BIO Singapore Summit Concludes Successfully!
On August 14–15, 2025, the Asia BIO Innovation Summit 2025—the most influential industry event in Asia’s biopharmaceutical sector—concluded successfully in Singapore. Centered on antibody‑drug conjugates (ADCs) and cell and gene therapies (CGTs), this global summit brought together leading pharmaceutical companies, research institutions, and investment firms from across Asia and around the world, serving as a vital platform for cutting‑edge technological exchange, insights into industry trends, and strategic business collaborations. As an innovative force deeply engaged in antibody discovery and early‑stage R&D, Xichang Bio was invited to attend and delivered a keynote presentation on August 15, joining its global peers in exploring pathways to technological breakthroughs and co‑creating a vision for biopharmaceutical innovation.
29
2026
/
01
03
2025
/
12
20
2025
/
11
Subscription Information
Subscribe to receive updates from Xichang News.
Shanghai Constream biotechnology Co., Ltd
Phone:021-59255902
Address: Building 2, Floors 2–3, Lane 10688, Beiqing Road, Qingpu District, Shanghai
WeChat Official Account
Copyright © 2026 Shanghai Constream biotechnology Co., Ltd.